BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27062567)

  • 21. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.
    Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR
    Oncology; 2012; 83(5):292-9. PubMed ID: 22964877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer.
    Guo J; Wu M; Guo L; Zuo Q
    Bull Cancer; 2018 Feb; 105(2):146-154. PubMed ID: 29290332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neutrophil-lymphocyte ratio as a prognostic factor in gastric cancer].
    Ma JP; Wang Z; Lin JW; Wu KM; Chen JH; Chen CQ; Cai SR; He YL; Zhan WH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Dec; 14(12):944-7. PubMed ID: 22205454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
    Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
    Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research progress of peripheral blood count test in the evaluation of prognosis of gastric cancer].
    Xu Z; Cheng H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):236-240. PubMed ID: 28226360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High levels of platelet/lymphocyte ratio are associated with metastatic gastric cancer.
    Cetinkunar S; Guzel H; Emre Gokce I; Erdem H; Gulkan S; Aktimur R; Kucuk B; Imamoglu I; Kargici H
    J BUON; 2015; 20(1):78-83. PubMed ID: 25778300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.
    Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
    World J Surg; 2018 Jun; 42(6):1819-1825. PubMed ID: 29270656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of neutrophil-to-lymphocyte ratio as a predictor of lymph node metastasis in gastric cancer.
    Kosuga T; Konishi T; Kubota T; Shoda K; Konishi H; Shiozaki A; Okamoto K; Fujiwara H; Kudou M; Arita T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
    BMC Cancer; 2019 Dec; 19(1):1187. PubMed ID: 31805894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Value of the Neutrophil/Lymphocyte Ratio in Peritoneal and/or Metastatic Disease at Staging Laparoscopy for Gastric and Esophageal Adenocarcinoma.
    Grenader T; Plotkin Y; Mohammadi B; Dawas K; Hashemi M; Mughal M; Bridgewater JA
    J Gastrointest Cancer; 2015 Sep; 46(3):267-71. PubMed ID: 25952408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Preoperative Neutrophil to Lymphocyte Ratio and Postoperative Infectious Complications on Survival After Curative Gastrectomy for Gastric Cancer: A Single Institutional Cohort Study.
    Mohri Y; Tanaka K; Toiyama Y; Ohi M; Yasuda H; Inoue Y; Kusunoki M
    Medicine (Baltimore); 2016 Mar; 95(11):e3125. PubMed ID: 26986164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer.
    Nakayama Y; Gotohda N; Shibasaki H; Nomura S; Kinoshita T; Hayashi R
    Surg Today; 2014 Nov; 44(11):2146-52. PubMed ID: 24831660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer.
    Aizawa M; Gotohda N; Takahashi S; Konishi M; Kinoshita T
    World J Surg; 2011 Dec; 35(12):2717-22. PubMed ID: 21913135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic significance of inflammation-based markers in patients with recurrent gastric cancer.
    Migita K; Matsumoto S; Wakatsuki K; Ito M; Kunishige T; Nakade H; Kitano M; Nakatani M; Sho M
    Surg Today; 2018 Mar; 48(3):282-291. PubMed ID: 28836056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer.
    Kawahara T; Yokomizo Y; Ito Y; Ito H; Ishiguro H; Teranishi J; Makiyama K; Miyoshi Y; Miyamoto H; Yao M; Uemura H
    BMC Cancer; 2016 Feb; 16():111. PubMed ID: 26883640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis.
    Zhang X; Zhang W; Feng LJ
    PLoS One; 2014; 9(11):e111906. PubMed ID: 25401500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Neutrophil-to-Lymphocyte Ratio as a Marker of Lymph Node Status in Patients with Rectal Cancer.
    Khan AA; Akritidis G; Pring T; Alagarathnam S; Roberts G; Raymond R; Varcada M; Novell R
    Oncology; 2016; 91(2):69-77. PubMed ID: 27288007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
    Cimen HI; Halis F; Saglam HS; Gokce A
    Int Braz J Urol; 2017; 43(1):67-72. PubMed ID: 28124528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.
    Shibutani M; Maeda K; Nagahara H; Noda E; Ohtani H; Nishiguchi Y; Hirakawa K
    Anticancer Res; 2013 Aug; 33(8):3291-4. PubMed ID: 23898094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer.
    Namikawa T; Munekage E; Munekage M; Maeda H; Yatabe T; Kitagawa H; Kobayashi M; Hanazaki K
    Oncology; 2016; 90(6):321-6. PubMed ID: 27225990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.